Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants

P Vuković, FA Peccatori, C Massarotti… - Critical Reviews in …, 2021 - Elsevier
Critical Reviews in Oncology/Hematology, 2021Elsevier
The detection of germline BRCA1/2 pathogenic variant has relevant implications for the
patients and their family members. Family planning, prophylactic surgery and the possibility
of preimplantation genetic testing for monogenic disorders (PGT-M) to avoid transmittance of
pathogenic variants to the offspring are relevant topics in this setting. PGT-M is valuable
option for BRCA carriers, but it remains a controversial and underdiscussed topic. Although
the advances in PGT technologies have improved pregnancy rate, there are still several …
Abstract
The detection of germline BRCA1/2 pathogenic variant has relevant implications for the patients and their family members. Family planning, prophylactic surgery and the possibility of preimplantation genetic testing for monogenic disorders (PGT-M) to avoid transmittance of pathogenic variants to the offspring are relevant topics in this setting.
PGT-M is valuable option for BRCA carriers, but it remains a controversial and underdiscussed topic. Although the advances in PGT technologies have improved pregnancy rate, there are still several important challenges associated with its use.
The purpose of this review is to report the current evidence on PGT-M for BRCA1/2 carriers, ethical concerns and controversy associated with its use, reproductive implications of BRCA pathogenic variants, underlying areas in which an educational effort would be beneficial as well as possibilities for future research efforts in the field.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果